These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

402 related items for PubMed ID: 30075103

  • 1. Deregulation of the endocannabinoid system and therapeutic potential of ABHD6 blockade in the cuprizone model of demyelination.
    Manterola A, Bernal-Chico A, Cipriani R, Canedo-Antelo M, Moreno-García Á, Martín-Fontecha M, Pérez-Cerdá F, Sánchez-Gómez MV, Ortega-Gutiérrez S, Brown JM, Hsu KL, Cravatt B, Matute C, Mato S.
    Biochem Pharmacol; 2018 Nov; 157():189-201. PubMed ID: 30075103
    [Abstract] [Full Text] [Related]

  • 2. Activation of CB2 receptor is required for the therapeutic effect of ABHD6 inhibition in experimental autoimmune encephalomyelitis.
    Wen J, Ribeiro R, Tanaka M, Zhang Y.
    Neuropharmacology; 2015 Dec; 99():196-209. PubMed ID: 26189763
    [Abstract] [Full Text] [Related]

  • 3. WWL70 attenuates PGE2 production derived from 2-arachidonoylglycerol in microglia by ABHD6-independent mechanism.
    Tanaka M, Moran S, Wen J, Affram K, Chen T, Symes AJ, Zhang Y.
    J Neuroinflammation; 2017 Jan 10; 14(1):7. PubMed ID: 28086912
    [Abstract] [Full Text] [Related]

  • 4. The serine hydrolase ABHD6 controls the accumulation and efficacy of 2-AG at cannabinoid receptors.
    Marrs WR, Blankman JL, Horne EA, Thomazeau A, Lin YH, Coy J, Bodor AL, Muccioli GG, Hu SS, Woodruff G, Fung S, Lafourcade M, Alexander JP, Long JZ, Li W, Xu C, Möller T, Mackie K, Manzoni OJ, Cravatt BF, Stella N.
    Nat Neurosci; 2010 Aug 10; 13(8):951-7. PubMed ID: 20657592
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The constitutive production of the endocannabinoid 2-arachidonoylglycerol participates in oligodendrocyte differentiation.
    Gomez O, Arevalo-Martin A, Garcia-Ovejero D, Ortega-Gutierrez S, Cisneros JA, Almazan G, Sánchez-Rodriguez MA, Molina-Holgado F, Molina-Holgado E.
    Glia; 2010 Dec 10; 58(16):1913-27. PubMed ID: 20878765
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The serine hydrolases MAGL, ABHD6 and ABHD12 as guardians of 2-arachidonoylglycerol signalling through cannabinoid receptors.
    Savinainen JR, Saario SM, Laitinen JT.
    Acta Physiol (Oxf); 2012 Feb 10; 204(2):267-76. PubMed ID: 21418147
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects.
    Long JZ, Li W, Booker L, Burston JJ, Kinsey SG, Schlosburg JE, Pavón FJ, Serrano AM, Selley DE, Parsons LH, Lichtman AH, Cravatt BF.
    Nat Chem Biol; 2009 Jan 10; 5(1):37-44. PubMed ID: 19029917
    [Abstract] [Full Text] [Related]

  • 12. Re-examining the potential of targeting ABHD6 in multiple sclerosis: Efficacy of systemic and peripherally restricted inhibitors in experimental autoimmune encephalomyelitis.
    Manterola A, Bernal-Chico A, Cipriani R, Ruiz A, Pérez-Samartín A, Moreno-Rodríguez M, Hsu KL, Cravatt BF, Brown JM, Rodríguez-Puertas R, Matute C, Mato S.
    Neuropharmacology; 2018 Oct 10; 141():181-191. PubMed ID: 30171986
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Inhibition of the endocannabinoid-regulating enzyme monoacylglycerol lipase elicits a CB1 receptor-mediated discriminative stimulus in mice.
    Owens RA, Mustafa MA, Ignatowska-Jankowska BM, Damaj MI, Beardsley PM, Wiley JL, Niphakis MJ, Cravatt BF, Lichtman AH.
    Neuropharmacology; 2017 Oct 10; 125():80-86. PubMed ID: 28673548
    [Abstract] [Full Text] [Related]

  • 15. Attenuation of anticipatory nausea in a rat model of contextually elicited conditioned gaping by enhancement of the endocannabinoid system.
    Limebeer CL, Abdullah RA, Rock EM, Imhof E, Wang K, Lichtman AH, Parker LA.
    Psychopharmacology (Berl); 2014 Feb 10; 231(3):603-12. PubMed ID: 24043345
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Impact of tetrahydrocannabinol on the endocannabinoid 2-arachidonoylglycerol metabolism: ABHD6 and ABHD12 as novel players in human placenta.
    Maia J, Fonseca BM, Cunha SC, Braga J, Gonçalves D, Teixeira N, Correia-da-Silva G.
    Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Dec 10; 1865(12):158807. PubMed ID: 32829065
    [Abstract] [Full Text] [Related]

  • 18. Brain regional cannabinoid CB(1) receptor signalling and alternative enzymatic pathways for 2-arachidonoylglycerol generation in brain sections of diacylglycerol lipase deficient mice.
    Aaltonen N, Riera Ribas C, Lehtonen M, Savinainen JR, Laitinen JT.
    Eur J Pharm Sci; 2014 Jan 23; 51():87-95. PubMed ID: 24012970
    [Abstract] [Full Text] [Related]

  • 19. Selective inhibition of alpha/beta-hydrolase domain 6 attenuates neurodegeneration, alleviates blood brain barrier breakdown, and improves functional recovery in a mouse model of traumatic brain injury.
    Tchantchou F, Zhang Y.
    J Neurotrauma; 2013 Apr 01; 30(7):565-79. PubMed ID: 23151067
    [Abstract] [Full Text] [Related]

  • 20. Study of the regulation of the endocannabinoid system in a virus model of multiple sclerosis reveals a therapeutic effect of palmitoylethanolamide.
    Loría F, Petrosino S, Mestre L, Spagnolo A, Correa F, Hernangómez M, Guaza C, Di Marzo V, Docagne F.
    Eur J Neurosci; 2008 Aug 01; 28(4):633-41. PubMed ID: 18657182
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.